뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 3mg;  ;   - film coated tablet - 3 mg - active: risperidone 3mg     excipient: colloidal silicon dioxide hypromellose   lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc quinoline yellow sodium laurilsulfate titanium dioxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 4mg;  ;   - film coated tablet - 4 mg - active: risperidone 4mg     excipient: colloidal silicon dioxide hypromellose   indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose propylene glycol purified talc quinoline yellow sodium laurilsulfate titanium dioxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 1 mg/ml (r064766);  ;   - oral solution - 1 mg/ml - active: risperidone 1 mg/ml (r064766)     excipient: benzoic acid purified water sodium hydroxide as 1n solution, to ph 3.0 tartaric acid - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 0.5mg - orodispersible tablet - 0.5 mg - active: risperidone 0.5mg excipient: aspartame carbomer gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 1mg - orodispersible tablet - 1 mg - active: risperidone 1mg excipient: aspartame carbomer gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 2mg; risperidone 2mg - orodispersible tablet - 2 mg - active: risperidone 2mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide active: risperidone 2mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 3mg - orodispersible tablet - 3 mg - active: risperidone 3mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 4mg - orodispersible tablet - 4 mg - active: risperidone 4mg excipient: aspartame carbomer 934p gelatin glycine iron oxide red mannitol peppermint oil polacrilin simeticone sodium hydroxide xanthan gum - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

스페인 - 스페인어 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - risperidona - comprimido bucodispersable - 0,5 mg - risperidona 0,5 mg - risperidona

스페인 - 스페인어 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

janssen cilag s.a. - risperidona - comprimido bucodispersable - 1 mg - risperidona 1 mg - risperidona